<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00730938</url>
  </required_header>
  <id_info>
    <org_study_id>Kikuyu01</org_study_id>
    <nct_id>NCT00730938</nct_id>
  </id_info>
  <brief_title>The Effect of Intracameral Cefuroxime on Post-op Fibrin in Pediatric Cataract Surgery</brief_title>
  <official_title>The Effect of Intracameral Cefuroxime on Post-op Fibrin in Pediatric Cataract Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Presbyterian Church East Africa Kikuyu Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Presbyterian Church East Africa Kikuyu Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study investigates whether placing an antibiotic inside the eye at the end of cataract
      surgery in children will reduce the amount of fibrin formation (fibrin formation can block
      the pupil and reduce vision). We hypothesize that the fibrin is caused by a low-level
      infection and could be prevented by the antibiotic.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study investigates whether using an antibiotic (cefuroxime) in the anterior chamber of
      the eye at the end of surgery for cataract in children will reduce the amount of fibrin
      formation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">July 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fibrin formation in anterior chamber</measure>
    <time_frame>4th postoperative day</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Cataract</condition>
  <condition>Endophthalmitis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cefuroxime</intervention_name>
    <description>intracameral cefuroxime 0.1 ml</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Zinacef</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline placebo</intervention_name>
    <description>0.1 ml of Ringers lactate</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  bilateral congenital or developmental pediatric cataract

        Exclusion Criteria:

          -  traumatic cataract
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dan Gradin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PCEA Kikuyu Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Presbyterian Church East Africa Kikuyu Hospital</name>
      <address>
        <city>Kikuyu</city>
        <zip>00902</zip>
        <country>Kenya</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Kenya</country>
  </location_countries>
  <verification_date>August 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2008</study_first_submitted>
  <study_first_submitted_qc>August 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2008</study_first_posted>
  <last_update_submitted>August 7, 2008</last_update_submitted>
  <last_update_submitted_qc>August 7, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dan Gradin, MD</name_title>
    <organization>Presbyterian Church East Africa Kikuyu Hospital</organization>
  </responsible_party>
  <keyword>fibrin</keyword>
  <keyword>endophthalmitis</keyword>
  <keyword>cataract extraction</keyword>
  <keyword>Lens</keyword>
  <keyword>implantation,</keyword>
  <keyword>intraocular</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Endophthalmitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cefuroxime</mesh_term>
    <mesh_term>Cefuroxime axetil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

